145 related articles for article (PubMed ID: 32070645)
1. Clinical audit of gentamicin use by Bayesian pharmacokinetic approach in critically ill children.
Sridharan K; Al Daylami A
J Infect Chemother; 2020 Jun; 26(6):540-548. PubMed ID: 32070645
[TBL] [Abstract][Full Text] [Related]
2. Dose Optimization of Gentamicin in Critically Ill Neonates.
Sridharan K; Al Jufairi M; Qader AM; Elsegai OAM
Curr Drug Metab; 2020; 21(4):270-280. PubMed ID: 32394828
[TBL] [Abstract][Full Text] [Related]
3. Extended-interval gentamicin: population pharmacokinetics in pediatric critical illness.
Lopez SA; Mulla H; Durward A; Tibby SM
Pediatr Crit Care Med; 2010 Mar; 11(2):267-74. PubMed ID: 19770786
[TBL] [Abstract][Full Text] [Related]
4. Determinants of gentamicin concentrations in critically ill patients: a population pharmacokinetic analysis.
Hodiamont CJ; Juffermans NP; Bouman CS; de Jong MD; Mathôt RA; van Hest RM
Int J Antimicrob Agents; 2017 Feb; 49(2):204-211. PubMed ID: 28038961
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic outcomes of a simplified, weight-based, extended-interval gentamicin dosing protocol in critically ill neonates.
Hoff DS; Wilcox RA; Tollefson LM; Lipnik PG; Commers AR; Liu M
Pharmacotherapy; 2009 Nov; 29(11):1297-305. PubMed ID: 19857147
[TBL] [Abstract][Full Text] [Related]
6. Dose derivation of once-daily dosing guidelines for gentamicin in critically ill pediatric patients.
Zakova M; Pong S; Trope A; Atenafu EG; Papaioannou V; Bitnun SA; Richardson S; Schwartz S; Cox P; Parshuram C; Seto W
Ther Drug Monit; 2014 Jun; 36(3):288-94. PubMed ID: 24695354
[TBL] [Abstract][Full Text] [Related]
7. Clinical Pharmacokinetics of Vancomycin in Critically Ill Children.
Sridharan K; Al Daylami A; Ajjawi R; Al-Ajooz H; Veeramuthu S
Eur J Drug Metab Pharmacokinet; 2019 Dec; 44(6):807-816. PubMed ID: 31301023
[TBL] [Abstract][Full Text] [Related]
8. Acute kidney injury in non-critically ill children treated with aminoglycoside antibiotics in a tertiary healthcare centre: a retrospective cohort study.
Zappitelli M; Moffett BS; Hyder A; Goldstein SL
Nephrol Dial Transplant; 2011 Jan; 26(1):144-50. PubMed ID: 20591815
[TBL] [Abstract][Full Text] [Related]
9. A gentamicin pharmacokinetic population model and once-daily dosing algorithm for neonates.
DiCenzo R; Forrest A; Slish JC; Cole C; Guillet R
Pharmacotherapy; 2003 May; 23(5):585-91. PubMed ID: 12741432
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic Drug Monitoring of Gentamicin Peak Concentrations in Critically Ill Patients.
Hodiamont CJ; Janssen JM; de Jong MD; Mathôt RA; Juffermans NP; van Hest RM
Ther Drug Monit; 2017 Oct; 39(5):522-530. PubMed ID: 28682925
[TBL] [Abstract][Full Text] [Related]
11. An extended interval dosing method for gentamicin in neonates.
Stickland MD; Kirkpatrick CM; Begg EJ; Duffull SB; Oddie SJ; Darlow BA
J Antimicrob Chemother; 2001 Dec; 48(6):887-93. PubMed ID: 11733474
[TBL] [Abstract][Full Text] [Related]
12. Once-daily gentamicin dosing in children with febrile neutropenia resulting from antineoplastic therapy.
Inparajah M; Wong C; Sibbald C; Boodhan S; Atenafu EG; Naqvi A; Dupuis LL
Pharmacotherapy; 2010 Jan; 30(1):43-51. PubMed ID: 20030472
[TBL] [Abstract][Full Text] [Related]
13. Expanded gentamicin volume of distribution in critically ill adult patients receiving total parenteral nutrition.
Ronchera-Oms CL; Tormo C; Ordovás JP; Abad J; Jiménez NV
J Clin Pharm Ther; 1995 Oct; 20(5):253-8. PubMed ID: 8576291
[TBL] [Abstract][Full Text] [Related]
14. Simulated Comparison of a Bayesian Clinical Decision Support System Versus Standard of Care For Achieving Gentamicin Pharmacokinetic Targets in Neonates.
Yu CZ; Myers SR; Faldasz JD
Pediatr Infect Dis J; 2020 Apr; 39(4):313-317. PubMed ID: 32032171
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and Target Attainment of Antibiotics in Critically Ill Children: A Systematic Review of Current Literature.
Hartman SJF; Brüggemann RJ; Orriëns L; Dia N; Schreuder MF; de Wildt SN
Clin Pharmacokinet; 2020 Feb; 59(2):173-205. PubMed ID: 31432468
[TBL] [Abstract][Full Text] [Related]
16. Extended-Interval Dosing of Gentamicin Aiming for a Drug-Free Period in Neonates: A Prospective Cohort Study.
van Maarseveen EM; Sprij A; Touw DJ
Ther Drug Monit; 2016 Jun; 38(3):402-6. PubMed ID: 26836810
[TBL] [Abstract][Full Text] [Related]
17. Gentamicin Pharmacokinetics and Monitoring in Pediatric Patients with Febrile Neutropenia.
Bialkowski S; Staatz CE; Clark J; Lawson R; Hennig S
Ther Drug Monit; 2016 Dec; 38(6):693-698. PubMed ID: 27851686
[TBL] [Abstract][Full Text] [Related]
18. Use of 4-mg/kg/24-hour empiric aminoglycoside dosing in preoperative neonates with congenital heart disease.
Moffett BS; Rossano JW
Ann Pharmacother; 2012 Sep; 46(9):1193-7. PubMed ID: 22911340
[TBL] [Abstract][Full Text] [Related]
19. Clinical Pharmacokinetics of Gentamicin in Various Patient Populations and Consequences for Optimal Dosing for Gram-Negative Infections: An Updated Review.
Hodiamont CJ; van den Broek AK; de Vroom SL; Prins JM; Mathôt RAA; van Hest RM
Clin Pharmacokinet; 2022 Aug; 61(8):1075-1094. PubMed ID: 35754071
[TBL] [Abstract][Full Text] [Related]
20. Using population pharmacokinetics to determine gentamicin dosing during extended daily diafiltration in critically ill patients with acute kidney injury.
Roberts JA; Field J; Visser A; Whitbread R; Tallot M; Lipman J; Kirkpatrick CM
Antimicrob Agents Chemother; 2010 Sep; 54(9):3635-40. PubMed ID: 20547809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
